vimarsana.com
Home
Live Updates
Mskcc Prognostic Model - Breaking News
Pages:
2
3
4
5
6
7
8
Mskcc Prognostic Model News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Genetic Counseling for Patients with Non-Clear Cell RCC
The panel closes their discussion with a look at the standards for genetic counseling for patients with non-clear cell RCC.
New wave
Renal cell carcinoma
Non clear cell
Renal cell carcinoma treatment
Asco gu 2023
Asco gu rcc
Rcc treatment
Clear cell rcc
Non clear cell rcc
Imdc risk
Intermediate risk
Tumor shrinkage
Dose reduction
Mskcc prognostic model
Best Approaches and Emerging Data in the Treatment of Non-Clear Cell RCC
The panel discusses the best approaches to treating patients with non-clear cell RCC.
New wave
Renal cell carcinoma
Emerging data
Non clear cell
Renal cell carcinoma treatment
Asco gu 2023
Asco gu rcc
Rcc treatment
Clear cell rcc
Non clear cell rcc
Imdc risk
Intermediate risk
Tumor shrinkage
Dose reduction
Mskcc prognostic model
Treatment Approaches for Patients with RCC Disease Progression After Adjuvant Therapy
Mehmet Asim Bilen, MD, explains how he would treat a patient with renal cell carcinoma who had disease progression after adjuvant therapy.
Mehmet asim bilen
New wave
Renal cell carcinoma
Progression after adjuvant
Asim bilen
Renal cell carcinoma treatment
Asco gu 2023
Asco gu rcc
Rcc treatment
Clear cell rcc
Non clear cell rcc
Imdc risk
Intermediate risk
Tumor shrinkage
Dose reduction
Mskcc prognostic model
Updates in the Adjuvant Treatment of Metastatic RCC
The panel discusses recent clinical trial data in the adjuvant treatment of metastatic renal cell carcinoma.
New wave
Renal cell carcinoma
Adjuvant treatment
Renal cell carcinoma treatment
Asco gu 2023
Asco gu rcc
Rcc treatment
Clear cell rcc
Non clear cell rcc
Imdc risk
Intermediate risk
Tumor shrinkage
Dose reduction
Mskcc prognostic model
Factoring Quality-of-Life, Liver Metastases, and Brain Metastases into Treatment Decision-Making for RCC
The panel discusses the use of quality-of-life clinical trial data in metastatic renal cell carcinoma and how liver and brain metastases affect treatment decision-making.
New wave
Renal cell carcinoma
Liver metastases
Brain metastases
Treatment decision making
Renal cell carcinoma treatment
Asco gu 2023
Asco gu rcc
Rcc treatment
Clear cell rcc
Non clear cell rcc
Imdc risk
Intermediate risk
Tumor shrinkage
Dose reduction
Mskcc prognostic model
vimarsana © 2020. All Rights Reserved.